Expression of interleukin-8 detected byin situ hybridization correlates with worse prognosis in primary cutaneous melanoma
- 1 December 1999
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 189 (4) , 546-551
- https://doi.org/10.1002/(sici)1096-9896(199912)189:4<546::aid-path487>3.0.co;2-l
Abstract
Previous in vitro studies have demonstrated that endogenously produced human interleukin‐8 (IL‐8) can act as an important growth factor for human melanoma cells in vitro. The present study, has investigated whether IL‐8 mRNA expression in primary melanomas may be of prognostic relevance with regard to melanoma progression and metastatic spread. In order to evaluate the clinical significance of IL‐8 mRNA expression of melanoma cells in vivo, 59 melanocytic tissue specimens (37 primary melanomas and 22 melanocytic naevi) were studied using a semiquantitative in situ hybridization technique. Significant mRNA expression of IL‐8 was found in 59 per cent (22/37) of melanomas. In 19 per cent (7/37) of the malignant melanomas, additional hybridization signals were noted within keratinocytes of the overlying epidermis. In contrast, paralesional normal‐appearing epidermis and melanocytes in non‐malignant lesions (melanocytic naevi) showed no IL‐8 mRNA. Analysis of the relationship between IL‐8 expression and clinico‐histopathological features showed a significant association between IL‐8 mRNA expression and the histological melanoma subtype (IL‐8 mRNA: 14/19 in superficial spreading melanoma versus 4/12 in nodular melanoma, p< 0·05). Furthermore, IL‐8 expression in primary tumours could be correlated with the patients' clinical course, with time to progression being significantly reduced in primary tumours expressing IL‐8 in either the tumour cells or keratinocytes of the overlying epidermis. These results demonstrate for the first time that IL‐8 expression, as detected by in situ hybridization in primary tumours, may serve as a significant prognostic factor for tumour progression in human malignant melanoma. Copyright © 1999 John Wiley & Sons, Ltd.Keywords
This publication has 16 references indexed in Scilit:
- Human Chemokines: An UpdateAnnual Review of Immunology, 1997
- The Interplay between Primary and Secondary CytokinesDrugs, 1997
- Interleukin-8 Inhibits Non-Small Cell Lung Cancer Proliferation: A Possible Role for Regulation of Tumor Growth by Autocrine and Paracrine PathwaysJournal of Interferon & Cytokine Research, 1996
- Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimensMelanoma Research, 1995
- Production of multiple cytokines by cultured human melanomas*Experimental Dermatology, 1993
- Expression of cytokine genes, including IL-6, in human malignant melanoma cell linesMelanoma Research, 1992
- Interleukin-8 and MCAF: Novel Leukocyte Recruitment and Activating Cytokines (Part 1 of 2)Published by S. Karger AG ,1992
- Expression and Secretion of Leukocyte Chemotactic Cytokines by Normal Human Melanocytes and Melanoma CellsJournal of Investigative Dermatology, 1991
- Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8Biochemical and Biophysical Research Communications, 1990
- The Neutrophil-Activating Protein (NAP-1) Is Also Chemotactic for T LymphocytesScience, 1989